We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
5 hedge funds and large institutions have $70.4M invested in Decoy Therapeutics in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more funds holding
Funds holding: 4 → 5 (+1)
14% more capital invested
Capital invested by funds: $61.9M → $70.4M (+$8.5M)
61% less call options, than puts
Call options by funds: $183K | Put options by funds: $465K
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
$183K
Puts
$465K
Net Calls
-$282K
Net Calls Change
-$282K
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$10.2M |
Top Sellers
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$169K |
| 2 |
D.E. Shaw & Co
New York
|
-$140K |
| 3 |
Goldman Sachs
New York
|
-$131K |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$116K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$114K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Acadian Asset Management
Boston,
Massachusetts
| – | -$114K | – | – |
|
52
Citadel Advisors
Miami,
Florida
| – | -$104K | – | – |
|
|
CS
53
Credit Suisse
Zurich,
Switzerland
| – | -$104K | – | – |
|
|
54
D.E. Shaw & Co
New York
| – | -$140K | – | – |
|
|
55
Goldman Sachs
New York
| – | -$131K | – | – |
|
|
HCM
56
Highbridge Capital Management
New York
| – | -$116K | – | – |
|
|
PPA
57
Parametric Portfolio Associates
Seattle,
Washington
| – | -$109K | – | – |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| – | -$10K | – | – |
|
59
UBS Group
Zurich,
Switzerland
| – | -$21K | – | – |
|
|
VKH
60
Virtu KCG Holdings
New York
| – | -$169K | – | – |
|